PubMed Health⌕ Search

Biomedical subjects

R S Perry

Publications and source records attributed to R S Perry.

At least 19 recordsLinked to original sources
PubMed2006

Formation of a nematic fluid at high fields in Sr3Ru2O7.

In principle, a complex assembly of strongly interacting electrons can self-organize into a wide variety of collective states, but relatively few such states have been identified in practice. We report that, in the close vicinity of a metamagnetic quantum critical point, high-purity strontium ruthenate Sr3Ru2O7 possesses a large magnetoresistive anisotropy, consistent with the existence of an electronic nematic fluid. We discuss a striking phenomenological similarity between our observations and those made in high-purity two-dimensional electron fluids in gallium arsenide devices.

Journal Article↗
PubMed2006

Thermal conductivity in the vicinity of the quantum critical end point in Sr3Ru2O7.

Thermal conductivity of Sr3Ru2O7 was measured down to 40 mK and at magnetic fields through the quantum critical end point at Hc=7.85 T. A peak in the electrical resistivity as a function of the field was mimicked by the thermal resistivity. In the limit as T-->0 K, we find that the Wiedemann-Franz law is satisfied to within 5% at all fields, implying that there is no breakdown of the electron despite the destruction of the Fermi liquid state at quantum criticality. A significant change in disorder [from rho0(H=0 T)=2.1 to 0.5 microOmega cm] does not influence our conclusions. At finite temperatures, the temperature dependence of the Lorenz number is consistent with ferromagnetic fluctuations causing the non-Fermi liquid behavior as one would expect at a metamagnetic quantum critical end point.

Journal Article↗
PubMed2006

Fermi surface and quasiparticle excitations of Sr2RhO4.

The electronic structure of the layered 4d transition metal oxide Sr2RhO4 is investigated by angle resolved photoemission. We find well-defined quasiparticle excitations with a highly anisotropic dispersion, suggesting a quasi-two-dimensional Fermi-liquid-like ground state. Markedly different from the isostructural Sr2RuO4, only two bands with dominant Rh 4dxz,zy character contribute to the Fermi surface. A quantitative analysis of the photoemission quasiparticle band structure is in excellent agreement with bulk data. In contrast, it is found that state-of-the-art density functional calculations in the local density approximation differ significantly from the experimental findings.

Journal Article↗
PubMed2006

Metamagnetic quantum criticality in Sr3Ru2O7 studied by thermal expansion.

We report low-temperature thermal expansion measurements on the bilayer ruthenate Sr3Ru2O7 as a function of magnetic field applied perpendicular to the ruthenium-oxide planes. The field dependence of the c-axis expansion coefficient indicates the accumulation of entropy close to 8 T, related to an underlying quantum critical point. The latter is masked by two first-order metamagnetic transitions which bound a regime of enhanced entropy. Outside this region the singular thermal expansion behavior is compatible with the predictions of the itinerant theory for a two-dimensional metamagnetic quantum critical end point.

Journal Article↗
PubMed2006

Nested fermi surface and electronic instability in Ca3Ru2O7.

High-resolution angular resolved photoemission data reveal well-defined quasiparticle bands of unusually low weight, emerging in line with the metallic phase of Ca(3)Ru(2)O(7) below approximately 30 K . At the bulk structural phase transition temperature of 48 K, we find clear evidence for an electronic instability, gapping large parts of the underlying Fermi surface that appears to be nested. Metallic pockets are found to survive in the small, non-nested sections, constituting a low-temperature Fermi surface with 2 orders of magnitude smaller volume than in all other metallic ruthenates. The Fermi velocities and volumes of these pockets are in agreement with the results of complementary quantum oscillation measurements on the same crystal batches.

Journal Article↗
PubMed2005

Metamagnetic quantum criticality revealed by 17O-NMR in the itinerant metamagnet Sr3Ru2O7.

We have investigated the spin dynamics using 17O-NMR in the bilayered perovskite Sr3Ru2O7, which sits close to a metamagnetic quantum critical point. The nuclear spin-lattice relaxation rate divided by temperature 1/T1T is enhanced on approaching the metamagnetic critical field of approximately 7.9 T, and at the critical field 1/T1T continues to increase and does not show Fermi-liquid behavior down to 0.3 K. The temperature dependence of T1T in this region suggests the critical temperature Theta to be approximately 0 K, which is strong evidence that the spin dynamics possesses a quantum critical character. Comparison between uniform susceptibility and 1/T1T reveals that antiferromagnetic fluctuations instead of two-dimensional ferromagnetic fluctuations dominate the spin fluctuation spectrum at the critical field, which is unexpected for itinerant metamagnetism.

Journal Article↗
PubMed2005

Phase bifurcation and quantum fluctuations in Sr3Ru2O7.

The bilayer ruthenate Sr3Ru2O7 has been cited as a textbook example of itinerant metamagnetic quantum criticality. However, recent studies of the ultrapure system have revealed striking anomalies in magnetism and transport in the vicinity of the quantum critical point. Drawing on fresh experimental data, we show that the complex phase behavior reported here can be fully accommodated within the framework of a simple Landau theory. We discuss the potential physical mechanisms that underpin the phenomenology, and assess the capacity of the ruthenate system to realize quantum tricritial behavior.

Journal Article↗
PubMed2004

Disorder-sensitive phase formation linked to metamagnetic quantum criticality.

Condensed systems of strongly interacting electrons are ideal for the study of quantum complexity. It has become possible to promote the formation of new quantum phases by explicitly tuning systems toward special low-temperature quantum critical points. So far, the clearest examples have been appearances of superconductivity near pressure-tuned antiferromagnetic quantum critical points. We present experimental evidence for the formation of a nonsuperconducting phase in the vicinity of a magnetic field-tuned quantum critical point in ultrapure crystals of the ruthenate metal Sr3Ru2O7, and we discuss the possibility that the observed phase is due to a spin-dependent symmetry-breaking Fermi surface distortion.

Journal Article↗
PubMed2004

de Haas-van Alphen effect across the metamagnetic transition in Sr3Ru2O7.

We report a study of the de Haas-van Alphen (dHvA) effect on the itinerant metamagnet Sr3Ru2O7. Extremely high sample purity allows the observation of dHvA oscillations both above and below the metamagnetic transition field of 7.9 T. The quasiparticle masses are fairly large away from the transition, and are enhanced by up to an extra factor of 3 as the transition is approached, but the Fermi surface topography change is quite small. The results are qualitatively consistent with a field-induced Stoner transition in which the mass enhancement is the result of critical fluctuations.

Journal Article↗
PubMed2004

Multiple first-order metamagnetic transitions and quantum oscillations in ultrapure Sr3Ru2O7.

We present measurements on ultraclean single crystals of the bilayered ruthenate metal Sr3Ru2O7, which has a magnetic-field-tuned quantum critical point. Quantum oscillations of differing frequencies can be seen in the resistivity both below and above its metamagnetic transition. This frequency shift corresponds to a small change in the Fermi surface volume that is qualitatively consistent with the small moment change in the magnetization across the metamagnetic transition. Very near the metamagnetic field, unusual behavior is seen. There is a strong enhancement of the resistivity in a narrow field window, with a minimum in the resistivity as a function of temperature below 1 K that becomes more pronounced as the disorder level decreases. The region of anomalous behavior is bounded at low temperatures by two first-order phase transitions. The implications of the results are discussed.

Journal Article↗
PubMed2002

Sensitivity to disorder of the metallic state in the ruthenates.

We report the results of transport measurements on SrRuO3, Sr3Ru2O7, and CaRuO3. In SrRuO3 and Sr3Ru2O7, our findings are consistent with the predictions of Fermi liquid theory, in contrast to previous reports based on samples with much shorter mean free paths. In CaRuO3, however, a T1.5 power law is seen in the resistivity in the high purity samples studied here. Our work gives concrete evidence that even the metallic state of the ruthenates is highly sensitive to disorder.

Journal Article↗
PubMed2001

Magnetic field-tuned quantum criticality in the metallic ruthenate Sr3Ru2O7.

The concept of quantum criticality is proving to be central to attempts to understand the physics of strongly correlated electrons. Here, we argue that observations on the itinerant metamagnet Sr3Ru2O7 represent good evidence for a new class of quantum critical point, arising when the critical end point terminating a line of first-order transitions is depressed toward zero temperature. This is of interest both in its own right and because of the convenience of having a quantum critical point for which the tuning parameter is the magnetic field. The relationship between the resultant critical fluctuations and novel behavior very near the critical field is discussed.

Journal Article↗
PubMed2001

Metamagnetism and critical fluctuations in high quality single crystals of the bilayer ruthenate Sr3Ru2O7.

We report the results of low temperature transport, specific heat, and magnetization measurements on high quality single crystals of the bilayer perovskite Sr3Ru2O7, which is a close relative of the unconventional superconductor Sr2RuO4. Metamagnetism is observed, and transport and thermodynamic evidence for associated critical fluctuations is presented. These relatively unusual fluctuations might be pictured as variations in the Fermi surface topography itself.

Journal Article↗
PubMed1986

Basic cardiac electrophysiology and mechanisms of antiarrhythmic agents.

Basic cardiac electrophysiology and how it applies to antiarrhythmic drug therapy are reviewed. Normal impulse propagation through the heart proceeds in sequence from the sinoatrial (SA) node, through the atrial specialized conducting system, the atrioventricular (AV) node, the His-Pur-kinje system, and into the ventricles. The cardiac cell maintains a resting membrane potential until an electrical stimulus depolarizes the cell and generates an action potential. The action potential is composed of five phases that represent the changing ionic fluxes and membrane potentials of the cardiac cell. The heart contains two types of cardiac conducting fibers. The fast- and slow-current action potentials generated by these fiber types exhibit distinctly different electrophysiologic properties. Cardiac arrhythmias generally result from an abnormality in the rate, rhythm, or conduction of an electrical impulse in the heart. They may be described as disturbances in normal impulse initiation (automaticity), impulse conduction, or both. Various portions of the conduction system are under the control of the autonomic nervous system, which depends on the balance between the activity of the parasympathetic and sympathetic nervous systems. Intracellular and extracellular concentrations of potassium, calcium, and magnesium have important effects on the electrophysiology of the heart. These changes can be critical in the production of various arrhythmias or may affect the efficacy or toxicity of various antiarrhythmic agents. The electrophysiology of quinidine, procainamide, disopyramide, lidocaine, tocainide, phenytoin, flecainide, amiodarone, and bretylium tosylate is discussed to detail the relationship between drug action and antiarrhythmic efficacy. The electrophysiologic effects of beta-blocking agents and calcium-channel antagonists are also presented. This basic primer on cardiac electrophysiology should provide the practitioner with an improved understanding of the effects, indications, and limitations of antiarrhythmic drugs.

Action Potentials↗
PubMed1986

Contemporary recommendations for evaluating and treating hyperlipidemia.

The biochemistry, etiology, and evaluation of hyperlipidemia and its management, including dietary and drug therapies, are discussed. Strong evidence supports the role of increased cholesterol concentrations as an independent risk factor for coronary artery disease (CAD); however, evidence that elevated triglyceride concentrations are also an independent risk factor remains questionable. The cornerstone of the laboratory diagnosis of hyperlipidemia involves repeated measurement of serum or plasma cholesterol and triglyceride concentrations. The goals of therapy should be to reduce cholesterol or triglyceride concentrations or both to below the 75th percentile, modify co-existing risk factors, individualize the treatment, and minimize any adverse effects. Specific interventions must be determined on the basis of patient age, gender, etiology of hyperlipidemia, presence of other risk factors, and degree of lipid abnormality. The majority of patients may be managed with dietary therapy alone. The three-phase diet developed by the American Heart Association emphasizes a gradual reduction in cholesterol and fats with the substitution of polyunsaturated for saturated fats. Patients at risk for CAD with sustained elevations in plasma cholesterol concentrations above the 95th percentile or a triglyceride concentration above 500 mg/dL after an adequate dietary trial should be considered for drug therapy. The effects of cholestyramine and colestipol hydrochloride, niacin, dextrothyroxine, clofibrate, neomycin sulfate, probucol, gemfibrozil, and mevinolin and compactin on lipids and lipoproteins are reviewed. Hyperlipidemia should be managed systematically using information about the association between increased lipid concentrations and CAD, patient risk factors, and limitations of both diet and drug therapy.

Clofibrate↗
PubMed1974

Mechanisms for differential block among single myelinated and non-myelinated axons by procaine.

1. The differential sensitivity of saphenous nerve fibres in the cat to block by procaine HCl was re-examined by recording identifiable unit action potentials from small nerve filaments.2. Small myelinated axons were blocked more quickly than large myelinated axons, but this differential effect could not be accounted for by differences in anaesthetic concentration requirements.3. The onset of block in non-myelinated axons was slower than or equal to that of small myelinated axons depending on anaesthetic concentration.4. Absolute differential block of non-myelinated and small myelinated axons was obtained by limiting the length of axons exposed to procaine to 2 mm.5. Differential rates of blocking among myelinated axons appear to depend on differences in the length of axons that must be exposed to blocking concentrations of procaine and to arise from the irregular distribution of such concentrations within an exposed nerve.

Action Potentials↗